Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 11Other hematologic neoplasm 5Plasma cell 1Myeloid 1Gastrointestinal 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Glioblastoma 80Brain Neoplasms 34Gliosarcoma 30Glioma 24Astrocytoma 18Central Nervous System Neoplasms 11Medulloblastoma 9Oligodendroglioma 5Neuroblastoma 5Ganglioneuroblastoma 5Ependymoma 4Diffuse Intrinsic Pontine Glioma 4Neoplasms 3Breast Neoplasms 3Meningeal Carcinomatosis 2Melanoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Untreated Childhood Anaplastic Astrocytoma 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Recurrence 1Rare Diseases 1Prostatic Neoplasms 1Pinealoma 1

Interventions

Radiotherapy 6Temozolomide 5Flow Cytometry 5Cyclophosphamide 5Therapeutics 4Psychiatric Rehabilitation 4Melphalan 4Magnetic Resonance Spectroscopy 4Filgrastim 4sargramostim 3Specimen Handling 3Polymerase Chain Reaction 3Methylprednisolone 3liposomal amphotericin B 2Topotecan 2Thiotepa 2Rituximab 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Itraconazole 2Immunologic Techniques 2Fentanyl 2Early Intervention, Educational 2Dexamethasone 2Caspofungin 2Carmustine 2Calcium Dobesilate 2Busulfan 2Aprepitant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Radiation × CNS × Clear all
NCT03528642 2026-05-13

Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma

National Cancer Institute (NCI)

Phase 1 Active not recruiting
40 enrolled
CNSLymphoid

Astrocytoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡